Fidelity Disruptive Medicine ETF (FMED)

Assets	$51.42M
Expense Ratio	0.50%
PE Ratio	39.71
Shares Out	1.62M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	9,123
Open	32.01
Previous Close	31.66
Day's Range	31.70 - 32.01
52-Week Low	23.48
52-Week High	32.89
Beta	0.77
Holdings	77
Inception Date	Apr 16, 2020

About FMED

Fund Home Page

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is issued by Fidelity.

• Asset Class: Equity
• Category: Health
• Stock Exchange: Nasdaq
• Ticker Symbol: FMED
• ETF Provider: Fidelity

Top 10 Holdings

46.30% of assets

Name	Symbol	Weight
Fidelity Securities Lending Cash Central Fund	n/a	13.04%
10x Genomics, Inc.	TXG	6.09%
Natera, Inc.	NTRA	4.47%
Thermo Fisher Scientific Inc.	TMO	4.08%
Danaher Corporation	DHR	3.75%
Illumina, Inc.	ILMN	3.61%
Revolution Medicines, Inc.	RVMD	2.89%
LifeStance Health Group, Inc.	LFST	2.87%
argenx SE	ARGX	2.86%
Sartorius Stedim Biotech S.A.	DIM	2.64%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 20, 2024	$0.112	Dec 24, 2024
Jun 21, 2024	$0.001	Jun 25, 2024

Performance

FMED had a total return of 26.59% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.57%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Oct 3, 2026

Data Sources Report a data error